Immunotherapy: Therapeutic potential of genetically modified HBV-specific T cells for chronic HBV infection and HBV-related HCC

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 2, 2011, Pages 61-

  Wood, Natalie J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SPECIFICITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; LIVER CELL CARCINOMA; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC ORGANISM;

EID: 79751500644     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.221     Document Type: Note

References (3)

1. ORIGINAL ARTICLE Gehring, A. J. et al. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. doi:10.1016/j.jhep.2010.10.025 (2010)
2. FURTHER READING Lau, G. K. et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 25, 1497-1501 (1997) (Pubitemid 27250775)
3. Johnson, L A. et al. Gene therapy with mouse and human T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114, 535-546 (2009)